MC38-hCD47/hCLDN18.2/hHER3
品系基本信息
验证数据
Ⅰ.In vitro Expression of MC38-hCD47/hCLAUDIN18.2/hHER3 cell line
The human CD47 , human claudin18.2 and human HER3 protein expression in the MC38-hCD47/hCLAUDIN18.2/hHER3 cells were measured by Flow Cytometry.
Figure 1. The expression of hCD24 , hCLAUDIN18.2 and hHER3 in MC38-hCD47/hCLAUDIN18.2/hHER3 cell line
Ⅱ.Characterization of in vivo growth kinetics
To test the take rates, and the tumor growth characteristics of MC38-hCD47/hCLAUDIN18.2/hHER3 cell line, cells were subcutaneously inoculated into the C57BL/6 mice.
Figure 2. Tumor growth curve of MC38-hCD47/hCLAUDIN18.2/hHER3 syngeneic model
Figure 3. Body weight change of MC38-hCD47/hCLAUDIN18.2/hHER3 syngeneic model
Ⅲ.Expression of hCD47/hCLAUDIN18.2/hHER3 protein in tumors
To verify the human CD47 , human claudin18.2 and human HER3 protein expression, the tumors were dissected and separated for single cell suspension.
Figure 4. The expression of hCD47 , hCLAUDIN18.2 and hHER3 in humanized modified tumors by FACS
你也可能感兴趣
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
查看
